Clinical Division Genetic Testing and Next Generation Sequencing Services for Active Clinical Protocols- bone marrow failure syndromes, aplastic anemia, myeloid neoplasms, clonal hematopoiesis, and related hematologic disorders
75N98026Q01002 · HEALTH AND HUMAN SERVICES, DEPARTMENT OF
A GENERAL MEDICAL AND SURGICAL HOSPITALS solicitation, performed in Bethesda, MD, with responses due 2026-09-08. AwardCast estimates what this specific solicitation will close for, before you bid.
What's being bought
See attached Notice of Intent and Statement of Work for details.
Comparable recent awards in GENERAL MEDICAL AND SURGICAL HOSPITALS
| Winner | Award value | Offers | Date |
|---|---|---|---|
| TMA LASER GROUP INC | $435K | n/a | 2026-06-30 |
| BOSTON SCIENTIFIC CORP | $23K | 1 | 2026-06-29 |
| TMA LASER GROUP INC | $174K | n/a | 2026-06-24 |
| TMA LASER GROUP INC | $900K | 1 | 2026-06-24 |
| SEVEN CORNERS INC | $195K | 1 | 2026-06-18 |
Questions
What is solicitation 75N98026Q01002 ?
Clinical Division Genetic Testing and Next Generation Sequencing Services for Active Clinical Protocols- bone marrow failure syndromes, aplastic anemia, myeloid neoplasms, clonal hematopoiesis, and related hematologic disorders, issued by HEALTH AND HUMAN SERVICES, DEPARTMENT OF, under NAICS 622110 (GENERAL MEDICAL AND SURGICAL HOSPITALS), performed in Bethesda, MD. Responses are due 2026-09-08.
What do similar contracts close for?
Comparable closed awards in this category ran from $23K to $900K, across 5 awards shown above. Those are historical results, not a forecast for this solicitation.
Explore the market
Forecast Report — what a specific solicitation will close for: the predicted price range, the competition to expect, and comparable awards already closed. Before you price your bid.
Every forecast is scored against the real award once it becomes public. See the track record.
Closed awards from public federal data, not the forecast. One email, no account.
Or get the forecast for this solicitation — $49, one report.